Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Blast Pharma Ltd (NASDAQ:ORPN)

1.73
Delayed Data
As of Jul 28
 -0.01 / -0.57%
Today’s Change
1.53
Today|||52-Week Range
7.95
-55.30%
Year-to-Date
No recent news for Bio Blast Pharma Ltd.

Today’s Trading

Previous close1.74
Today’s open1.73
Day’s range1.70 - 1.77
Volume67,729
Average volume (3 months)207,399
Market cap$28.5M
Dividend yield--
Data as of 07/28/2016

Growth & Valuation

Earnings growth (last year)-89.47%
Earnings growth (this year)-10.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
ICCCImmuCell Corp-0.18-2.56%
VTGNVistaGen Therapeutic...-0.11-3.19%
CANFCan Fite Biopharma L...-0.04-1.90%
CLSNCelsion Corp-0.05-3.91%
Data as of 07/28/2016

Financials

Next reporting dateAugust 19, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$15.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Colin J. Foster
Chief Financial Officer
Bob Cook
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs